The Provider Directory is provided on an "AS-IS" basis. WebMD disclaims all warranties, either express or implied, including but not limited to the implied warranties of merchantability and fitness for particular purpose. Without limiting the foregoing, WebMD does not warrant or represent that the Provider Directory or any part thereof is accurate or complete. You assume full responsibility for the communications with any Provider you contact through the Provider Directory. WebMD shall in no event be liable to you or to anyone for any decision made or action taken by you in the reliance on information provided in the Provider Directory.
In patients with recurrent optic neuritis secondary to multiple sclerosis, there are approved disease-modifying agents that reduce disease activity and disease progression for many people with relapsing forms of MS, including relapsing-remitting MS, as well as progressive forms of MS in those people who experience relapses. These include injectable forms of interferon beta, glatiramer acetate, and the biologic monoclonal antibody, daclizumab . Oral medications include teriflunomide ( Aubagio ), fingolimod ( Gilenya ), and dimethyl fumarate .
Just behind the iris and pupil lies the lens, which helps focus light on the back of your eye . Most of the eye is filled with a clear gel called the vitreous. Light projects through your pupil and lens to the back of the eye. The inside lining of the eye is covered by special light-sensing cells that are collectively called the retina. It converts light into electrical impulses. Behind the eye, your optic nerve carries these impulses to the brain . The macula is a small extra-sensitive area in the retina that gives you central vision.